BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28084616)

  • 1. Piperacillin-tazobactam-induced linear IgA bullous dermatosis presenting clinically as Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.
    Adler NR; McLean CA; Aung AK; Goh MS
    Clin Exp Dermatol; 2017 Apr; 42(3):299-302. PubMed ID: 28084616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
    Baltazard T; Dhaille F; Duvert-Lehembre S; Lok C; Chaby G
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A toxic epidermal necrolysis-like presentation of linear IgA bullous dermatosis treated with dapsone.
    Nguyen JK; Koshelev MV; Gill BJ; Boulavsky J; Diwan AH; Dao H
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature.
    Kakar R; Paugh H; Jaworsky C
    Dermatology; 2013; 227(3):209-13. PubMed ID: 24135381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced linear IgA bullous dermatosis simulating toxic epidermal necrolysis.
    Nasr J; Ammoury A; Chouairy C; Mégarbané H; El Habr C
    J Med Liban; 2014; 62(3):176-9. PubMed ID: 25306799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome.
    Jones DH; Todd M; Craig TJ
    J Am Osteopath Assoc; 2004 Apr; 104(4):157-63. PubMed ID: 15127983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear Immunoglobulin A (IgA) Bullous Dermatosis Mimicking Stevens-Johnson Syndrome.
    Park JS; Hamilton CD; Patel S; Lee JB; Hsu S
    Cureus; 2022 Oct; 14(10):e30309. PubMed ID: 36381872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis.
    Pereira AR; Moura LH; Pinheiro JR; Pasin VP; Enokihara MM; Porro AM
    An Bras Dermatol; 2016; 91(5 suppl 1):35-38. PubMed ID: 28300888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced Linear IgA Bullous Dermatosis: A Case Report and Review of the Literature.
    Lammer J; Hein R; Roenneberg S; Biedermann T; Volz T
    Acta Derm Venereol; 2019 May; 99(6):508-515. PubMed ID: 30809685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
    Waldman MA; Black DR; Callen JP
    Clin Exp Dermatol; 2004 Nov; 29(6):633-6. PubMed ID: 15550142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced linear immunoglobulin A bullous dermatosis mimicking Stevens-Johnson syndrome: a case report.
    Cummings JE; Snyder RR; Kelly EB; Raimer SS
    Cutis; 2007 Mar; 79(3):203-7. PubMed ID: 17674585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin-Tazobactam-Induced Linear IgA Bullous Dermatosis Supported by a T-Cell Activation Assay.
    Ho YH; Chiu YW; Liu HN
    Ann Dermatol; 2018 Oct; 30(5):588-591. PubMed ID: 33911483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the α3 subunit of laminin-332.
    Zenke Y; Nakano T; Eto H; Koga H; Hashimoto T
    Br J Dermatol; 2014 Apr; 170(4):965-9. PubMed ID: 24641255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causative drug detection by drug-induced lymphocyte stimulation test in drug-induced linear IgA bullous dermatosis.
    Tomida E; Kato Y; Ozawa H; Hasegawa H; Ishii N; Hashimoto T; Akiyama M
    Br J Dermatol; 2016 Nov; 175(5):1106-1108. PubMed ID: 26265104
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker.
    Adachi M; Adachi T; Yokota M; Ichimura C; Yoshida K; Ishii K; Ishiko A
    J Dermatol; 2021 Dec; 48(12):e610-e611. PubMed ID: 34561902
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.
    Garel B; Ingen-Housz-Oro S; Afriat D; Prost-Squarcioni C; Tétart F; Bensaid B; Bara Passot C; Beylot-Barry M; Descamps V; Duvert-Lehembre S; Grootenboer-Mignot S; Jeudy G; Soria A; Valnet-Rabier MB; Barbaud A; Caux F; Lebrun-Vignes B
    Br J Clin Pharmacol; 2019 Mar; 85(3):570-579. PubMed ID: 30511379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms.
    Chanal J; Ingen-Housz-Oro S; Ortonne N; Duong TA; Thomas M; Valeyrie-Allanore L; Lebrun-Vignes B; André C; Roujeau JC; Chosidow O; Wolkenstein P
    Br J Dermatol; 2013 Nov; 169(5):1041-8. PubMed ID: 23815152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case of shift from linear immunoglobulin A bullous dermatosis to pemphigus herpetiformis for a short period of time.
    Koga H; Ishii N; Hashimoto T; Nakama T
    J Dermatol; 2017 Feb; 44(2):189-193. PubMed ID: 28497856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin-induced linear IgA bullous dermatosis: associations.
    Gameiro A; Gouveia M; Tellechea O; Goncalo M
    Dermatol Online J; 2016 Apr; 22(4):. PubMed ID: 27617457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis.
    Dellavalle RP; Burch JM; Tayal S; Golitz LE; Fitzpatrick JE; Walsh P
    J Am Acad Dermatol; 2003 May; 48(5 Suppl):S56-7. PubMed ID: 12734475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.